Table 5.
Total number of patients, n (%) | 102 (16.6*) |
Subjective outcome, n (%) | |
° Complete remission | 68 (66.7) |
° Improvement | 30 (29.4) |
° No improvement | 4 (3.9) |
Objective outcome, n (%) | |
° No positional nystagmus | 31 (30.4) |
° Less positional nystagmus | 40 (39.2) |
° Unchanged positional nystagmus | 3 (2.9) |
° Incomplete data | 28 (27.5) |
Decisionmaker when treatment was discontinued | |
° Examiner | 78 (77.2) |
° Patient** | 23 (22.8) |
Reason for discontinuation by the examiner | |
° Complete treatment success | 70 (89.7) |
° No further effect of treatments | 8 (10.3) |
With the group of patients that required more than five treatments, 98 patients (96.1%) experienced improvement of subjective symptoms and 71 patients (69.6%) had improvement of objective findings.
22 out of 635 (3.5%) patients had ongoing treatment or were lost to follow-up at the time of data collection.
All patients decided to discontinue treatments due to satisfactory subjective treatment results.